Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “4-9 Years of Age”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Study completedNCT04425291
What this trial is testing

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 1,680
Not applicableNot Yet RecruitingNCT06929247
What this trial is testing

Clinical and Radiographic Evaluation of Pulpotomy Using Neoputty MTA Versus Pulpectomy Using Metapex in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis in Children Aged 4 to 9 Years.

Who this might be right for
Pulpitis - Irreversible
Mohamed Nashaat Mohamed 70
Not applicableLooking for participantsNCT03882827
What this trial is testing

Natural History of Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Genethon 220
Early research (Phase 1)Not Yet RecruitingNCT06925490
What this trial is testing

Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis

Who this might be right for
Irreversible PulpitisPrimary TeethPulp Disease, Dental
Cairo University 50
Not applicableStudy completedNCT02611739
What this trial is testing

Medi-Port Pilot Randomized Controlled Trial

Who this might be right for
Actively Undergoing Cancer Treatment4-9 Years of AgeAt Least 1 Month From Diagnosis+2 more
The Hospital for Sick Children 40
Large-scale testing (Phase 3)Study completedNCT02697474
What this trial is testing

Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.

Who this might be right for
Hepatitis B
Sanofi Pasteur, a Sanofi Company 150